Senior Director, Head of Commercial Operations and Analytics

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.

The Senior Director, Head of Commercial Operations will build and lead the commercial operations and analytics capabilities required to support Capricor's anticipated U.S. launch of deramiocel, its lead cell therapy for Duchenne muscular dystrophy. This leader will establish the operational backbone of the commercial organization, including commercial data and analytics, forecasting, field operations, customer relationship management, territory design, incentive compensation, performance reporting, and commercial systems.

This is a hands-on launch leadership role with end-to-end accountability for translating commercial strategy into scalable processes, actionable insights, and disciplined execution. The position will partner closely with Sales, Marketing, Market Access, Patient Services, Finance, Medical Affairs, IT, Legal, and Compliance, as well as external data, analytics, and technology partners, to establish launch-ready capabilities and evolve them as the business grows.